Praćenje onkoloških bolesnika – kliničke preporuke Hrvatskog društva za internističku onkologiju HLZ-a III. dio: neuroendokrine neoplazme, hepatocelularni karcinom, rak gušterače, rak žučnih vodova [Cancer patients follow-up – Croatian society of medical oncology clinical guidelines Part III: neuroendocrine neoplasms, hepatocellular carcinoma, pancreatic cancer, cancer of the bile ducts]

Dedić Plavetić, Natalija and Kelemenić Dražin, Renata and Dobrila Dintinjana, Renata and Radić, Mladen and Prejac, Juraj and Mišetić Dolić, Zrinka and Pavlović, Mirjana and Škegro, Mate and Šeparović, Robert and Vrbanec, Damir (2016) Praćenje onkoloških bolesnika – kliničke preporuke Hrvatskog društva za internističku onkologiju HLZ-a III. dio: neuroendokrine neoplazme, hepatocelularni karcinom, rak gušterače, rak žučnih vodova [Cancer patients follow-up – Croatian society of medical oncology clinical guidelines Part III: neuroendocrine neoplasms, hepatocellular carcinoma, pancreatic cancer, cancer of the bile ducts]. Liječnički vjesnik, 138 (7-8). pp. 173-178. ISSN 0024-3477

PDF - Published Version Download (845kB)

Abstract

The treatment of oncological patients must be based upon multidisciplinary approach, and takes place in specialized oncological centers. By the end of a specific oncological treatment further follow-up is being managed mostly by the oncologists, but the role of the general practitioners becomes more important every day and therefore should be precisely defined. Nowadays, most of the existing follow-up guidelines are not based on prospective studies, but on the experts opinion of individual oncological centers or specialists. The aim of the Croatian Society of Medical Oncology (CSMO) with these recommendations is to standardize and rationalize the diagnostic procedures algorithm in the follow-up of oncological patients after primary treatment, in patients with neuroendocrine neoplasms, hepatocellular carcinoma, pancreatic cancer and cancer of the bile ducts.

Abstract in Croatian

Liječenje onkoloških bolesnika mora se temeljiti na multidisciplinarnom pristupu, a provodi se u specijaliziranim onkološkim centrima. Nakon završetka specifičnog onkološkog liječenja daljnje praćenje uglavnom provode onkolozi, ali je uloga liječnika primarne zdravstvene zaštite (PZZ) sve važnija i potrebno ju je jasno definirati. Trenutačno se većina preporuka za praćenje ne temelji na prospektivnim studijama, već se zasniva na stručnim mišljenjima pojedinih onkoloških centara ili specijalista. Hrvatsko društvo za internističku onkologiju (HDIO) ovim preporukama želi standardizirati i racionalizirati dijagnostičke postupke u praćenju onkoloških bolesnika, nakon završetka primarnog liječenja, u bolesnika s neuroendokrinim neoplazmama, hepatocelularnim karcinomom, rakom gušterače i rakom žučnih vodova.

Actions (login required)

View Item

Downloads